Jeffrey Kodroff Esq.

Spector Roesman Kodroff & Willis, P.C.
Kodroff, Jeffrey L.

Jeffrey Kodroff, a Partner in the law firm of in Philadelphia, concentrates his practice in complex antitrust, healthcare and consumer litigation. Mr. Kodroff was among the first attorneys to represent clients in litigation against national health maintenance organizations (HMOs).

He developed and filed the first private lawsuit against the pharmaceutical industry for its illegal marketing practices and use of the published average wholesale price which causes consumers, health and welfare funds and insurance companies to drastically overpay for certain drugs. The original case was against TAP Pharmaceutical, the manufacturer of the cancer drug Lupron, and Mr. Kodroff, as Lead Counsel, was instrumental in obtaining a $150 million recovery.

He has also served as lead or co-lead counsel in other substantial pharmaceutical marketing cases, including New England Carpenters Health Benefits Fund v. First Databank, Inc. and McKesson Corp., and District 37 Health and Securities Fund v. Medi-Span. To date, he has helped recover hundreds of millions of dollars of overpayment for pharmaceutical drugs.

Mr. Kodroff has served as a Continuing Legal Education presenter on class actions and health care issues as well as making presentations at the NCPERS Health Care Symposium and the Pennsylvania Public Employees Retirement System Conference. Mr. Kodroff also appeared with one of his clients before the U.S. House of Representatives, Subcommittee on Housing and Community Opportunity, Committee on Banking and Financial Services on the issue of predatory lending.

Mr. Kodroff received his B.S. from La Salle University and his J.D. from Temple University School of Law.